Search clinical trials for: SCH 727965

Total 2478 results

Merck Sharp & Dohme LLC

Completed

Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336) (VIDA)

Hepatitis C, Chronic | Genotype 1 | HCV-1
Merck Sharp & Dohme LLC

Completed

A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)

Acute Coronary Syndrome
Merck Sharp & Dohme LLC

Completed

Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

Hepatitis C, Chronic | Hepacivirus
Schering-Plough

Completed

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Hepatitis C, Chronic
Merck Sharp & Dohme LLC

Completed

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Solid Tumors
Ruijin Hospital

Unknown

Adaptive SCS for Treatment of Gait Disturbance in PD

Parkinson Disease | Gait Disorders, Neurologic

China
Merck Sharp & Dohme LLC

Completed

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) (ESAQUALITY)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (TIPS)

Psoriasis
Merck Sharp & Dohme LLC

Completed

A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) (REQUEST)

Rheumatoid Arthritis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Psoriasis
Merck Sharp & Dohme LLC
Hospital Universitario Reina Sofia de Cordoba; Dr. Jose María Martos Becerra...

Withdrawn

Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) (HACER)

Ankylosing Spondylitis
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy
Moens Maarten

Completed

HRV in Patients Treated With Spinal Cord Stimulation

Failed Back Surgery Syndrome

Belgium
Merck Sharp & Dohme LLC

Terminated

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

Hepatitis C, Chronic | Hepacivirus
Merck Sharp & Dohme LLC

Completed

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Melanoma
Nemours Children's Clinic

Recruiting

Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach

Sickle Cell Trait

United States
Fondazione Policlinico Universitario Agostino Gemelli...
Ministry of Health, Italy

Terminated

Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS (Bigeminy)

Acute Myeloid Leukemia | Myelodysplasia

Italy
Merck Sharp & Dohme LLC

Completed

Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) (ENCORE)

Crohn's Disease
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)

Crohn's Disease
Merck Sharp & Dohme LLC

Terminated

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Parkinsonian Disorders | Dyskinesia, Drug-Induced | Akathisia, Drug-Induced
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)

Rheumatoid Arthritis
Merck Sharp & Dohme LLC

Completed

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) (PHODYPSO)

Psoriasis
Universitair Ziekenhuis Brussel
the eNose company

Completed

Evaluating a Treatment Effect in Patients With FBSS Using an Electronic Nose: a Pilot Study (NOSE)

Failed Back Surgery Syndrome

Belgium
Stimgenics LLC

Completed

Stimgenics Open-Label, Post Market Study (SGX-SCS-RCT)

Chronic Low Back Pain

United States
Moens Maarten

Completed

Electrodermal Activity and Respiration in Patients Treated With Spinal Cord Stimulation

Failed Back Surgery Syndrome

Belgium
Organon and Co

Completed

A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

Hypercholesterolemia
King Faisal Specialist Hospital & Research Center

Unknown

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

Critical Limb Ischemia

Saudi Arabia
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Chronic Hepatitis C
Merck Sharp & Dohme LLC

Completed

Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)

Hepatitis C | Hepatitis C, Chronic
Nandan Lad, M.D., Ph.D.

Recruiting

Spinal Cord Stimulation (SCS) for Spinal Cord Injury (SCI)

Spinal Cord Injury at T1-T12 Level | Traumatic Thoracic Spinal Cord Contusion | Thoracic Spinal Cord Trauma | Traumatic Thoracic Spinal Cord Laceration | Post-Traumatic Thoracic Myelopathy | Traumatic Thoracic Spinal Cord Myelopathy

United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Hepatic Impairment

Hepatic Impairment

United States
Swiss Paraplegic Centre Nottwil
UMC Utrecht

Completed

Association of Quantitative and Functional Imaging With Clinical Outcome After Spinal Cord Injury

Spinal Cord Injuries

Switzerland
Universitair Ziekenhuis Brussel

Completed

Sweat Gland Function in Patients With Failed Back Surgery Syndrome, Treated With Spinal Cord Stimulation

Failed Back Surgery Syndrome

Belgium
Merck Sharp & Dohme LLC

Completed

Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)

Rheumatoid Arthritis
Organon and Co

Completed

To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)

Schizophrenia
TriHealth Inc.

Active, not recruiting

Pre-epidural SCDs to Prevent Hypotension During Labor

Hypotension | Labor Complication

United States
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) (ENHANCE)

Atherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
Imperial College London

Recruiting

Spinal Cord Stimulation for Gait Dysfunction in Parkinson's Disease (SCORE-PD)

Parkinson Disease | Freezing of Gait

United Kingdom
Merck Sharp & Dohme LLC
Duke Clinical Research Institute

Terminated

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)

Myocardial Infarction | Myocardial Ischemia | Atherosclerosis
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)

Arthritis, Rheumatoid
Merck Sharp & Dohme LLC

Terminated

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (REMission)

Arthritis, Rheumatoid | Psoriasis | Crohn's Disease | Arthritis, Psoriatic | Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC

Completed

Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)

Cough
Merck Sharp & Dohme LLC

Completed

An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)

Crohn's Disease
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Radiolabeled Danicopan in Healthy Male Participants

Healthy

New Zealand

3

Subscribe